Canakinumab vs placebo or usual care
All‐cause mortality D28
Canakinumab showed no clear difference in all‐cause mortality D28 compared with standard care/placebo (low certainty).
1 finding from 1 review
- RR 0.75 [0.39, 1.42]2 studies · 499 participantsLow